Cargando…
CRISPR screening in hematology research: from bulk to single-cell level
The CRISPR genome editing technology has revolutionized the way gene function is studied. Genome editing can be achieved in single genes or for thousands of genes simultaneously in sensitive genetic screens. While conventional genetic screens are limited to bulk measurements of cell behavior, recent...
Autores principales: | Meyers, Sarah, Demeyer, Sofie, Cools, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594891/ https://www.ncbi.nlm.nih.gov/pubmed/37875911 http://dx.doi.org/10.1186/s13045-023-01495-5 |
Ejemplares similares
-
High-Throughput CRISPR Screening in Hematological Neoplasms
por: Ancos-Pintado, Raquel, et al.
Publicado: (2022) -
The Updated European Hematology Association Research Roadmap
por: Engert, Andreas, et al.
Publicado: (2022) -
Applying CRISPR-Cas9 screens to dissect hematological malignancies
por: Iyer, Deepak Narayanan, et al.
Publicado: (2022) -
TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia
por: Thielemans, Naomi, et al.
Publicado: (2022) -
Open Access is the Plan S Way Forward in Hematology Research
por: Cools, Jan, et al.
Publicado: (2020)